Regional segmentation of gene synthesis market by Coherent Market Insights includes North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America gene
synthesis market is expected to hold a dominant position over the forecast period, due to
increased demand from biopharmaceutical companies and academic institutes, coupled with
presence of large number of industry players with strong distribution channel. For instance, in
2016, Twist Bioscience, revenue increased with US$ 61 million for scale-up and commercial
operation of its silicon chip-based high throughput low-cost gene synthesis platform. Increasing
R&D expenditure by pharmaceutical and biotech companies for up gradation of technology and
production output is expected to drive growth of gene synthesis market in Europe. For instance,
according to European Commission 2016 report, EU companies have significantly raised their
investment in R&D, rising above the world's average growth rate. Asia Pacific market is
expected to exhibit the highest growth rate, owing to increasing investment by government and
private organizations to support growth of synthetic biology. Japan is a leading Asian country
in synthetic biology with more private companies participating in synthetic biology research.
Competitive Analysis
Major players operating in the gene synthesis market include Atum, ATDBio Ltd., Bioneer
Corporation, Eurofins Scientific, Eurogentec, GenScript Biotech Corporation, Genewiz, Integrated
DNA Technologies, Inc., OriGene Technologies, Inc., and Thermo Fisher Scientific, Inc.
Companies are focusing on strengthening their sales force and expanding their production
facilities in various geographies. For instance, in 2016, Eurofins Lancaster Laboratories (Eurofins
Scientific), announced strategic plans for expansion of its Ireland campus, including development
of a new building, expansion of its facility, and increase its workforce. The International Gene
Synthesis Consortium (IGSC) is a group of gene synthesis organizations and companies that
applies and designs a common method to screen sequences of synthetic gene orders. The group
also works with international and national government organizations. Currently, the IGSC
members together comprises around 80% of commercial gene synthesis capacity worldwide.
Buy This Premium Research Report:
https://www.coherentmarketinsights.com/insight/buy-now/1533
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.